Literature DB >> 183071

Effects of bromocriptine on central dopaminergic receptors.

M Trabucchi, P F Spano, G C Tonon, L Frattola.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183071     DOI: 10.1016/0024-3205(76)90394-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  14 in total

Review 1.  Pharmacological and molecular basis for dopamine D-2 receptor diversity.

Authors:  M Memo
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

2.  Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.

Authors:  R Horowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

3.  Primary tissue culture of human adrenocortical Conn's adenomata. Bromocriptine as a possible agonist-antagonist of angiotensin at the cellular level.

Authors:  U Armato; F Mantero
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

4.  Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.

Authors:  G Anlezark; B Meldrum
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

Review 5.  Bromocriptine in the treatment of parkinsonism.

Authors:  J D Parkes
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

6.  Suppression of REM rebound by Pergolide.

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

7.  Oxpentifylline in Parkinson's disease.

Authors:  R B Godwin-Austen; J A Twomey; G Hanks; J Higgins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

8.  Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.

Authors:  P Onali; J P Schwartz; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Effects of three dopamine agonists on cage climbing behavior.

Authors:  G Gianutsos; J L Palmeri
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Dopaminergic and non-dopaminergic neurons in substantia nigra: differential response to bromocriptine.

Authors:  E Scarnati; C Forchetti; G Ciancarelli; C Pacitti; A Agnoli
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.